Heart scans may unlock hidden risks in minority communities

NCT ID NCT06610019

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study is looking at whether advanced heart imaging, especially cardiac MRI, can help identify the cause of cardiomyopathy and predict risks like death or heart failure in a diverse group of patients. The research focuses on adults in the Bronx, including many from Hispanic and African American backgrounds, who are referred for a heart MRI. By tracking health outcomes over time, the study aims to build better risk models for these often-underrepresented groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cardiovascular magnetic resonance (CMR) imaging and other advanced imaging modalities
What this could lead to
If successful, this could lead to better risk prediction and tailored treatment strategies for cardiomyopathy in minority populations.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The findings may not apply to other regions or ethnic groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDERSON FABRY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montefiore Health System

    RECRUITING

    The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.